Novavax CEO contends COVID vaccine is 'more stable' than alternatives, could reduce 'all disease'

Posted on AllSides July 21st, 2022
From The Right

Novavax President and CEO Stanley Erck asserted the biotech's COVID-19 vaccine endorsed by the CDC for adults is "quite a bit different" than its alternatives, telling "Cavuto: Coast to Coast" Thursday it is "more stable" and could possibly reduce "all disease."

STANLEY ERCK: It’s quite a bit different, we have a vaccine that like the others have shown great efficacy and a great safety database. Ours is a bit more stable than the others, so you can distribute the vaccine and use it at refrigerated temperatures instead of having to take it at...

Read full story

More News about Healthcare from the Left, Center and Right

From the Left

From the Center

From the Right